Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
2.490
-0.220 (-8.12%)
At close: Sep 18, 2026, 4:00 PM EDT
2.500
+0.010 (0.40%)
After-hours: Sep 18, 2026, 7:48 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $7.94 million as of September 18, 2026. Its market cap has decreased by -30.36% in one year.
Market Cap
7.94M
Enterprise Value
-1.56M
1-Year Change
-30.36%
Ranking
Category
Stock Price
$2.49
ChartMarket Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $7.94M, a decrease of -95.40%. That is a compound annual growth rate of -42.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 7.94M | -26.46% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.98% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 23.01M |
| Polyrizon | 22.58M |
| TScan Therapeutics | 22.46M |
| Cellectar Biosciences | 22.40M |
| Psyence Biomedical | 22.39M |
| Cocrystal Pharma | 21.96M |
| GridAI Technologies | 21.03M |
| Neuphoria Therapeutics | 20.59M |